Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

Retrieved on: 2024-12-25 01:35:14

Tags for this article:

University of Pittsburgh Medical Center

University of Pittsburgh

University of Pittsburgh School of Medicine

New York University Grossman School of Medicine

Oncology

NCI-designated Cancer Center

UPMC Hillman Cancer Center

Pittsburgh

United States

University of Texas MD Anderson Cancer Center

Click the tags to see associated articles and topics

Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models. View article details on hiswai:

Excerpt

2Applied Bioinformatics Laboratories, Office of Science ... 5Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, ...

Article found on: www.jci.org

View Original Article